Advertisement

Picture BioM Munich Biomarker Conference 2015 München Germany December 600x60px
All >

Deals > Germany

Find below collaborations, license and distribution agreements, grants, investments and loan agreements from Germany or involving German organisations.

Total search results: 6522 | Ordered by Date (descending)
next pagenext page 1 2 3 4 ... 64 65 66  next pagenext page

order ascendingorder descendingDeal: Collaboration or Financing order ascendingorder descendingDate
Univ Furtwangen–Danaher: mass spectrometer, 201411 supply existent AB Sciex QTRAP 4000 system used by Prof Fath for water analysis 2014-11-13
Novartis–Qiagen: molecular companion diagnostics, 201411– collab €na master agreement devlepm + commercialisation of CDx for Novartis drugs 2014-11-11
Humedics–SEVERAL: investment, 201411 financing round Series C €6.3 led by new investors Vesalius Biocapital Partners + Seventure Partners 2014-11-10
Siemens–SEVERAL: investment, 201411 acquisition of Siemens Audiology Solutions for €2.15b plus earn-out by EQT + Strüngmann family 2014-11-06
Definiens–AstraZeneca: investment, 201411 acquisition $150m upfront + milestones by MedImmune 2014-11-04
Dihon Pharmaceutical–Bayer: investment, 201411 acquisition for CNY3.6b=€460m 2014-11-03
EBOKON project–Germany (govt): grant, 201411–201512 BMBF grant €2.3m to DZIF + partners for Ebola virus research 2014-11-01
MYR GmbH–High-Tech Gründerfonds: investment, 201410 financing round totalling €7.9m from Maxwell Biotech Venture Fund + HTGF 2014-10-31
MYR GmbH–Russia (govt): investment, 201410 financing round totalling €7.9m from Maxwell Biotech Venture Fund + HTGF 2014-10-31
MYR GmbH–SEVERAL: investment, 201410 financing round €7.9m from Maxwell Biotech Venture Fund + HTGF 2014-10-31
Deutsche Messe–Select Biosciences: European Lab Automation conference, 201410–201510 collab co-hosting of ELA 2015 + Labvolution 2015 in Hannover 2014-10-30
Bayer–DuPont: herbicides, 201410–201412 acquisition €na approx 30 herbicides for land management from DuPont Crop Protection by Bayer CropScience 2014-10-29
Eurofins–Igenbio: genomic services, 201410– collab product integration for one-stop-shopping solution by Eurofins Genomics + Igenbio 2014-10-29
Astellas–Qiagen: molecular companion diagnostics, 201410– collab €na master agreement devlepm + commercialisation of CDx for Astellas drugs 2014-10-28
Cunesoft–Bavaria (govt): investment, 201410 financing round with HTGF + Bayern Kapital 2014-10-28
Cunesoft–High-Tech Gründerfonds: investment, 201410 financing round with HTGF + Bayern Kapital 2014-10-28
Cunesoft–SEVERAL: investment, 201410 financing round with HTGF + Bayern Kapital 2014-10-28
Imevax–BioMedPartners: investment, 201410 financing round Series A totalling €7.5m incl co-lead investor BioMedInvest-II LP fund 2014-10-28
Imevax–EMBL: investment, 201410 financing round Series A totalling €7.5m incl co-lead investor EMBL Ventures 2014-10-28
Imevax–MC Services: public relations, 201410 service existent by MC Services AG 2014-10-28
Imevax–SEVERAL: investment, 201410 financing round Series A €7.5m led by Wellington Partners 2014-10-28
Imevax–Strüngmann Group: investment, 201410 financing round Series A totalling €7.5m incl co-lead investor Santo Venture Capital 2014-10-28
Imevax–Wellington Partners: investment, 201410 financing round Series A totalling €7.5m incl lead investor Wellington Partners 2014-10-28
National Cardiovascular Partners–Fresenius: investment, 201410 acquisition €na of NCP by Fresenius Medical Care 2014-10-22
YES Pharma Services–Auctus Capital: investment, 201410 acquisition of majority share by funds advised by Auctus Capital Partners AG 2014-10-22
VBC-Biotech–Eurofins: investment, 201410 acquisition merger establishing Eurofins Genomics AT GmbH taking over VBC services 2014-10-21
Weizmann Institute–XL-protein: PASylation technology, 201410– Yeda acquires ww excl marketing + outlicensing rights to PAS-YNSa8 dev by XL + Weizmann 2014-10-21
Epigenomics–BioChain: investment, 201410 acquisition €4.2m 1.35m new shares €3.08/share by BioChain Institute Inc 2014-10-16
MorphoSys–Lanthio Pharma: LanthioPep technology, 201410 acquisition €na technology + all related IP by MorphoSys 2014-10-15
Rigontec–Boehringer: investment, 201410 financing round Series A 1st closing totalling €9.45m co-led by Wellington Partners + BIVF 2014-10-14
Rigontec–High-Tech Gründerfonds: investment, 201410 financing round Series A 1st closing totalling €9.45m incl co-investor HTGF 2014-10-14
Rigontec–Huntsworth: public relations, 201410 service existent by Citigate Dewe Rogerson 2014-10-14
Rigontec–North Rhine-Westphalia (govt): investment, 201410 financing round Series A 1st closing totalling €9.45m incl co-investor NRW.Bank 2014-10-14
Rigontec–SEVERAL: investment, 201410 financing round Series A 1st closing €9.45m co-led by Wellington Partners + BIVF 2014-10-14
Rigontec–Wellington Partners: investment, 201410 financing round Series A 1st closing totalling €9.45m co-led by Wellington Partners + BIVF 2014-10-14
Probiodrug–Hume Brophy: public relations, 201410 service existent by Hume Brophy 2014-10-10
4 Animals AlsterScience–Hamburg (govt): investment, 201410 seed financing round from HTGF + Innovationsstarter Fonds + Business Angel 2014-10-09
4 Animals AlsterScience–High-Tech Gründerfonds: investment, 201410 seed financing round from HTGF + Innovationsstarter Fonds + Business Angel 2014-10-09
4 Animals AlsterScience–SEVERAL: investment, 201410 seed financing round from HTGF + Innovationsstarter Fonds + Business Angel 2014-10-09
Analytik Jena–PERSON: investment, 201410 DIVESTMENT Klaus Berka to sell his shares to Endress+Hauser (Deutschland) GmbH & Co KG 2014-10-01
Analytik Jena–Thuringia (govt): investment, 201410 DIVESTMENT TIB to sell shares in AJ to Endress+ Hauser (Deutschland) AG & Co KG 2014-10-01
Bayer–Belchim Crop Protection: fungicide, 201410– acquisition sole European distribution rights €na for biofungicide Contans WG by Bayer CropScience 2014-10-01
Curasan–SEVERAL: investment, 201410 capital increase w subscription rights €1.5m 2014-10-01
Imevax–Germany (govt): grant, 201410 GO-Bio Phase II grant €5.9m from BMBF 2014-10-01
Merck (US)–Bayer: sGC modulators, 201410– collab strategic alliance ww co-developm + co-commercialisation $1b upfront + $1.1b milestones 2014-10-01
Multi Channel Systems MCS–Harvard Bioscience: investment, 201410 acquisition €7.5m in cash by Harvard Bioscience 2014-10-01
Shimadzu–m/e Brand Communication: public relations, 201409 service existent 2014-09-29
Probiodrug–SEVERAL: investment, 201409–201410 IPO €23.2m at Euronext Amsterdam 2014-09-25
Fuchs Petrolub–BRAIN: lubricant, 201409– collab development of lubricants produced from renewable raw materials 2014-09-24
Sigma-Aldrich–Merck (DE): investment, 201409– acquisition $17b in cash ANNOUNCED 2014-09-22
Analytik Jena–Endress+Hauser: investment, 201409–201410 acquisition of addit 27.56% from Klaus Berka + TIB rasing share to 82.22% 2014-09-18
Boehringer–CureVac: RNActive vaccine, 20140901– collab developm + excl ww license for CV9202 €35m upfront + €430m milestones + royalties 2014-09-18
Merck (DE)–Lupin: pharmaceuticals, 201409– strategic alliance €na developm + dossiers + supply by Lupin + marketing Merck Serono in emerging markets 2014-09-16
MorphoSys–Germany (govt): grant, 201409– BMBF grant up to €1m to develop Ylanthia antibodies against two undisclosed GPCR targets 2014-09-15
SensoQuest–Eppendorf: thermal cycler, 201409– license covering gradient technology for thermal cyclers to SensoQuest GmbH 2014-09-15
Boehringer–Minapharm: rec protein production technology, 201409 license existent from ProBioGen 2014-09-09
Novartis–Minapharm: rec protein production technology, 201409 license existent from ProBioGen 2014-09-09
4SC–Yorkville Group: credit, 201409 second tranche €500k convertible notes under up to €15m agreem from 2/14 w YA Global Master SPV Ltd 2014-09-03
Affimed–Perceptive Advisors: credit, 201409– loan agreem over €10.5m 2014-09-02
Affimed–SEVERAL: investment, 201409 financing round Series E €11.7m led by existent investors 2014-09-02
Merck (DE)–S-Target Therapeutics: S-TIR technology, 201409– license excl ww €na to Allergopharma to develop antiallergics 2014-09-02
Bayer–MetaSysX: metabolomic services, 201409–201708 supply services to Bayer CropScience to improve agricultural productivity 2014-09-01
Berlin Cures–Helmholtz: investment, 201409 Ascenion acquires shares at time of spin-off from Charité + MDC in return for services 2014-09-01
CHDI–Evotec: drug discovery services, 201409–201708 collab service extension CDHI funding up to 52 full-time scientists for Huntington’s disease drugs 2014-09-01
Univ Hamburg–Bruker Corp: MPI system, 201409 supply installation of 1st commercial MPI PreClinical system at UKE 2014-09-01
BASF–Cenix BioScience: biomarker discovery + validation, 201408– supply service €na research framework agreement with Metanomics Health 2014-08-26
Recipe–Tecan: automated liquid handling, 201408– collab co-marketing of ClinMass LC-MSMS Complete Kits with Freedom EVO platform 2014-08-26
Eppendorf–Wallinger Ricker Schlotter Tostmann: legal services, 201408 Eppendorf is client of WRST with regard to gradient PCR patent litigation 2014-08-25
SensoQuest–Rehberg Hüppe: legal services, 201408 SensoQuest is client of RHP with regard to gradient PCR patent litigation 2014-08-25
Bruker Corp–F-DGSi: gas generator, 201408 supply + collab existent resale of F-DGSi gas generators by Bruker with Bruker instruments 2014-08-22
MorphoSys–Emergent BioSolutions: cancer antibody drug, 201408– collab developm + commercialisation rights or ES414 outside North America for MorphoSys 2014-08-19
Bruker Corp–CMS: legal services, 201408 service legal advice by CMS Hasche Sigle on acqu of Bruker’s ICP-MS business by Analytik Jena 2014-08-14
Lentigen–Miltenyi Biotec: investment, 201408 acquisition lentiviral manufacturing business + assets continuing as Miltenyi sub Lentigen Technology Inc 2014-08-14
Miltenyi Biotec–Scott Partnership: public relations, 201308 service existent by Phoenix MarCom 2014-08-14
Bruker Corp–Analytik Jena: investment, 201407–201409 acquisition €na of ICP-MS business from Bruker by AJ 2014-08-13
RayBiotech–Scienion: print/spotting technology, 201408– distribution €na of Scienion products in China by RayBiotech Inc 2014-08-13
Inocard–Uniqure: investment, 201408 acquisition of Inocard GmbH for €1.5m in cash + €1.5m in shares upfront plus milestones + royalties 2014-08-11
Sopat–High-Tech Gründerfonds: investment, 201408 DIVESTMENT sale of shares in Sopat by HTGF to Dr Max Iann Invest GmbH 2014-08-06
i3 Membrane–DBU: grant, 201408 existent €250k to support developm of steel-based membrane technology 2014-08-01
i3 Membrane–Hamburg (govt): investment, 201408 investment by Innovationsstarter Fonds Hamburg + HTGF 2014-08-01
i3 Membrane–High-Tech Gründerfonds: investment, 201408 investment by HTGF + Innovationsstarter Fonds Hamburg 2014-08-01
Medineering–High-Tech Gründerfonds: investment, 201408 seed financing round from HTGF + Bayern Kapital + Born2Grow + consortium of business angels 2014-08-01
Medineering–SEVERAL: investment, 201408 seed financing round from HTGF + Bayern Kapital + Born2Grow + consortium of business angels 2014-08-01
IBL International–Tecan: investment, 201407 acquisition €29m in cash 2014-07-30
Artes Biotechnology–Burnet Institute: malaria vaccine, 201407– collab development funded by PATH Malaria Vaccine Initiative (MVI) 2014-07-29
Artes Biotechnology–Burnet Institute: Metavax VLP technology, 201407 license existent Artes holds international patent rights 2014-07-29
Boehringer–Zealand Pharma: peptide drug, 201407– collab + ww excl rights for cardio-metabolic disease €295m milestones + research funding + royalties 2014-07-28
Boehringer–Univ Toronto: drug target discovery, 201407– collab to characterise new drug targets in ubiquitin system 2014-07-22
InflaRx–SEVERAL: investment, 201407 financing round Series B closing of 2nd + last tranche led by bm-t Thüringen 2014-07-17
LTS Lohmann Therapie-Systeme–Hopp Group: investment, 201407– acquisition all remaining shares by existent shareholder Dievini Hopp BioTech Holding 2014-07-17
Paion–Pharmascience: investment, 201407 private placement €4m with 1.27m new shares €3.15/share to Pharmasience Intl Ltd 2014-07-17
Biosynthetic Technologies–Evonik: investment, 201407 financing round incl Evonik Venture Capital + BP Ventures 2014-07-16
Immatics–SEVERAL: investment, 201407 financing round Series D 2nd tranche €22m of €34m round Hopp + Strüngmann + Wellington Partners et al 2014-07-16
Amcure–Germany (govt): grant, 201407 BMBF subsidy via Spinnovator programme managed by Ascenion 2014-07-15
Amcure–SEVERAL: investment, 201407 financing round Series A €5m led by LBBW Venture Capital GmbH 2014-07-15
Fosun–Miacom Diagnostics: molecular diagnostics, 201407– distribution molecular mulitplex sepsis + pneumonia assays by Fosun Diagnostics in CN + Asia 2014-07-14
Ayoxxa–SEVERAL: investment, 201407 financing round Series B €9m all existing investors + new investors 2014-07-10
International Council of Biotechnology Associations–BIO Deutschland: biotechnology, 201407 BIO Deutschland is founding member of ICBA 2014-07-10
International Council of Biotechnology Associations–VCI: biotechnology, 201407 DIB is founding member of ICBA 2014-07-10
Analyticon Discovery–BRAIN: investment, 201407 acquisition of majority share €na by BRAIN w remaining shares held by management + key personnel 2014-07-03
next pagenext page 1 2 3 4 ... 64 65 66  next pagenext page



Advertisement

Picture SwedenBIO Nordic Life Science Days 2015 Stockholm 600x60px

To subscribe to our free, monthly newsletter for the life sciences in German-speaking Europe (DE, AT & CH), please send an e-mail to info@iito.de and simply fill the subject line with the word »LSG newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture LSBC Central European Life Science Investment Conference 2015 600x60px

» top

Advertisements

Picture Universal Medica Innovations Days 2015 Paris France October 120x180px Picture EBD Group BIO Europe 2015 BEU Munich November 120x80px Picture BioM Munich Biomarker Conference 2015 München Germany December 120x180px Picture IQPC IP Life Sciences Exchange 2015 Frankfurt Germany 120x180px Picture SwedenBIO Nordic Life Science Days 2015 Stockholm 600x60px Picture LSBC Central European Life Science Investment Conference 2015 120x240px Picture BIO Deutschland European Business Development Conference 120x240px Picture EBD Group BioPharm America 2015 BPA Boston September 120x240px Banner Fairtec GmbH Solutions for Smarter Business Events Exhibitions 120x120px Banner [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px